中國醫藥大學機構典藏 China Medical University Repository, Taiwan:

瀏覽

子類別

	博碩士論文 [47/47]
	專利 [0/1]
	專書 [0/2]
	會議論文 [39/70]
	期刊論文 [234/284]
	研究計畫 [99/152]

鄰近社群

	免疫學研究所 [248/336]
	分子系統生物醫學研究所 [88/184]
	國際生物醫學碩士學位學程 [29/29]
	基礎醫學研究所 [647/878]
	新藥開發研究所 [9/9]
	生物醫學影像暨放射科學學系暨碩生班 [348/541]
	生物醫學研究所 [235/235]
	生醫科技產業博士學位學程 [2/2]
	癌症生物與藥物研發博士學位學程 [53/54]
	神經科學與認知科學研究所 [47/55]
	老化醫學博士學位學程 [26/26]
	臨床醫學研究所 [777/1184]
	轉譯醫學博士學位學程 [16/16]
	醫學檢驗生物技術學系暨碩士班 [395/924]
	醫學系 [2644/7110]
	醫學研究所 [300/354]

上傳排行

資料載入中.....

下載排行

資料載入中.....

跳至: [中文] [數字0-9] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]

請輸入前幾個字:

顯示項目26-50 / 556. (共23頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

日期	題名	作者
2010	Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents.	(Dong Y,); (Shi Q); (Nakagawa-Goto K,); (Wu PC); (Morris-Natschke SL); (Brossi A,); (Bastow, KF,); (Lang JY); 洪明奇(Mien-Chie Hung); (Lee, KH)*
2010-02	Antitumor Agents. 272. Structure-Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone Analogues	(Dong Y); (Shi Q); (Pai HC); (Peng CY); (Pan SL); (Teng CM); (Nakagawa-Goto K); (Yu D); (Liu YN); (Wu PC); (Bastow KF); (Morris-Natschke SL); (Brossi A); (Lang JY); (Hsu JL); 洪明奇(Mien-Chie Hung); (Lee EY); (Lee KH)*
2010	Antitumor agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent	(Usami, Y); (Nakagawa-Goto, K); (Lang, J-Y); (Kim, Y.); (Lai, C-Y); (Goto, M.); (Sakurai, N.); (Taniguchi, M); (Akiyama, T.); (Morris-Natschke, S. L.); (Bastow, K. F.); (Cragg, G.); (Newman, D.J.); (Fujitake, M.); (Takeya, K.); 洪明奇(Mien-Chie Hung); (Lee, E. Y-H. P.); (Lee, K-H.)*
2010	ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway	(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)*
2010	ARD1 stalization of TSC2 suppresses tumorigenesis via the mTOR signaling pathway	(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)*
2010-04	Aromatase Deficiency Inhibits the Permeability Transition in Mouse Liver Mitochondria	(Loredana Moro); (Arnaldo A. Arbini); 謝哲宗(Jer-Tsong Hsieh); (Jeffery Ford); (Evan R. Simpson); (Asghar Hajibeigi); (Orhan K. Oz)
2010	Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein	(Kuo, H-P); 洪明奇(Mien-Chie Hung)*
2014-08	ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1	(Zhang, P.); (Wei, Y.); (Wang, L.); (Debeb, B. G.); (Yuan, Y.); (Zhang, J.); (Yuan, J.); (Wang, M); (Chen, D.); (Sun, Y.); (Woodward, W. A.); (Liu, Y.); (Dean, D. C.); (Liang, H.); (Hu, Y.); (Ang, K); 洪明奇(Mien-Chie Hung); (Chen, J.); (Ma, L.)*
2010	Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2.	(Yang G); (Chang B); (Yang F); (Guo X); (Cai KQ); (Mercado-Uribe I); (Xiao X); (Wang H); (Sen S); 洪明奇(Mien-Chie Hung); (Mills GB); (Chang S,); (Multani A); (Liu J)*
2006-09	B2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis	(Wen-Chin Huang); (Daqing Wu); (Zhihui Xie); (Haiyen E. Zhau); (Takeo Nomura); (Jan Pohl); 謝嘉玲; (M. Neale Weitzmann); (Mary C. Farach-Carson); (Leland W.K. Chung)*
2013-12	BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib	黃偉謙(Wei-Chien Huang); (Yi-Ling Hsieh); (Chao-Ming Hung); (Pei-Hsuan Chien); (Yu-Fong Chien); (Lei-Chin Chen); 涂智彥(Chih-Yen Tu); 陳家弘(Chia-Hung Chen); (Sheng-Chieh Hsu); (Yueh-Ming Lin); (Yun- Ju Chen)*
2008-04	Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma	(Chia-Jui Yen); (Julie G. Izzo); (Dung-Fang Lee); (Sushovan Guha); (Yongkun Wei); (Tsung-Te Wu); (Chun-Te Chen); (Hsu-Ping Kuo); (Jung-Mao Hsu); (Hui-Lung Sun); (Chao-Kai Chou); (Navtej S. Buttar); (Kenneth K. Wang); (Peng Huang); (Jaffer Ajani); 洪明奇(Mien-Chie Hung)*
2010-03	Blockade of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase and Murine Double Minute Synergistically Induces Apoptosis in Acute Myeloid Leukemia via BH3-Only Proteins Puma and Bim.	(Zhang W); (Konopleva M); (Burks JK); (Dywer KC); (Schober WD); (Yang JY,); (McQueen TJ); 洪明奇(Mien-Chie Hung); (Andreeff M)*
2016-02	Blocking c-Met-mediated PAPR1 phosphorylation enhances anti-tumor effects of PARP inhibitors	(Du, Y.); (Yamaguchi, H.); (Wei, Y.); (Hsu, J. L.); (Wang, H-L.); (Hsu, Y-H.,); (Lin, W-C.); (Yu, W-H.); (Leonard, P. G.); (Lee, G-R. IV); (Chen, M-K.); (Nakai, K.); (Hsu, M-C.); (Chen, C-T.); (Sun, Y.); (Wu, Y.); 張為超(Wei-Chao Chang); (Huang, W-C.); (Liu, C-L.); (Chang, Y-C.); (Chen, C-H.); (Park, M.); (Jones, P.); (Hortobagyi, G. N.); 洪明奇(Mien-Chie Hung)*
2010-10	Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition	楊慕華(Muh-Hwa Yang); 許信翔(Dennis Shin-Shian Hsu); 王學偉(Hsei-Wei Wang); 王曉蓉(Hsiao-Jung Wang); (Hsin-Yi Lan); 楊文豪(Wen-Hao Yang); 黃奇宏(Chi-Hung Huang); 高壽延(Shou-Yen Kao); 曾成槐(Cheng-Hwai Tzeng); 戴世光(Shyh-Kuan Tai); 張學逸(Shyue-Yih Chang); 李光申(Oscar Kuang-Sheng Lee); 吳國瑞(Kou-Juey Wu)
2013	B型肝炎病毒X蛋白影響肝癌細胞對標靶藥物敏感度之探討	陳貞妤; Chen, Jhen-Yu
2009	Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival	佘玉萍(Yuh-Pyng Sher); (Tz-Fei Tzeng); (Shu-Fen Kan); (Jennifer Hsu); (Xiaoming Xie); (Zhenbo Han); 林文川(Wen-Chuan Lin); 李龍緣(Long-Yuan Li); 洪明奇(Mien-Chie Hung)
2012-07	Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma	(Chen-Shiou Wu); (Chia-Jui Yen); 鄒瑞煌(Ruey-Hwang Chou); (Shiou-Ting Li); 黃偉謙(Wei-Chien Huang); (Chien-Tai Ren); (Chung-Yi Wu); 余永倫(Yung-Luen Yu)
2011-04	Cancer-targeted gene therapy elicits protective anti-tumor immunity against lung cancer metastasis. Molecular Cancer Therapeutics.	佘玉萍(Yuh-Pyng Sher); 劉士任(Shih-Jen Liu); (Chang CM); (Lien SP); (Chen CH); (Han Z); 李龍緣(Long-Yuan Li); (Chen JS); (Wu CW); 洪明奇(Mien-Chie Hung)*
2011-11-21	Cancer-targeted gene therapy for delivering endostatin-cytosine deaminase fusion protein with 5-fluorocytosine suppresses ovarian tumor growth.	佘玉萍(Yuh-Pyng Sher); (Chun-Mien Chang); (Chiun-Gung Juo); (Chun-Te Chen); 林振源(Chen-Yuan Lin); (Zhenbo Han); (Shine-Gwo Shiah); 洪明奇(Mien-Chie Hung)*
2015-11	Carglumic acid promotes apoptosis and suppresses cancer cell proliferation in vitro and in vivo	(335. Chen, C-T.); (Chen, Y-C.); (Yamaguchi, H.); 洪明奇(Mien-Chie Hung)*
2015-07	CARMA3 Represses Metastasis-Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis	(Chang YW,); (Chiu CF); (Lee KY); (Hong CC); (Wang YY); (Cheng CC); (Jan YH); (Huang MS); (Hsiao M); (Ma JT); 蘇振良(Jen-Liang Su)*
2014-06	CCL5/RANTES is important for inducing osteogenesis of human mesenchymal stem cells and is regulated by dexamethasone	(Liu YC); (Kao YT); (Huang WK); (Lin KY); (Wu SC); (Hsu SC); (Schuyler SC); 李龍緣(Long-Yuan Li); (Leigh Lu F); (Lu J)*
2012-04-04	CCR5 and CCRL2 accommodating responses to CCL5 induces directional cancer cells migration and organ specific metastasis.	張惠雯; 李蕙汝; 謝嘉玲(Chia-Ling Hsieh); 宋賢穎(Shian-Ying Sung); 宋賢穎(Shian-Ying Sung); 宋賢穎(Shian-Ying Sung)*
2011-01	CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells	(Yongkun Wei); 陳雅惠(Ya-Huey Chen); 李龍緣(Long-Yuan Li); (Jingyu Lang); 葉士芃(Su-Peng Yeh); (Bin Shi); (Cheng-Chieh Yang); (Jer-Yen Yang); (Chun-Yi Lin); (Chien-Chen Lai); 洪明奇(Mien-Chie Hung)

顯示項目26-50 / 556. (共23頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

資料載入中.....

子類別

鄰近社群

最近上傳

上傳排行

下載排行